MedGenesis Therapeutix Inc.
This article was originally published in Start Up
Executive Summary
MedGenesis Therapeutix is developing convection-enhanced delivery, a technique that involves infusion under positive pressure of a drug to specific locations of the brain. The leading indication for its CED technology is glioblastoma.